CID 16130871

Human neutrophil peptide c (ttcycripaciagerrygtciyqgrlwafcctt)

Structural Information

Molecular Formula
C163H245N47O45S6
SMILES
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N4CCC[C@H]4C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N3)CC5=CC=C(C=C5)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@@H](C)CC)CC6=CC=C(C=C6)O)CCC(=O)N)CCCNC(=N)N)CC(C)C)CC7=CNC8=CC=CC=C87)C)CC9=CC=CC=C9)C(=O)N1)C)[C@@H](C)CC)CCCNC(=N)N)[C@@H](C)O)CC1=CC=C(C=C1)O)CCCNC(=N)N)CCCNC(=N)N)CCC(=O)O)C
InChI
InChI=1S/C163H245N47O45S6/c1-17-77(6)123-153(248)184-80(9)130(225)179-67-118(220)186-103(52-54-121(223)224)138(233)188-99(35-26-56-175-161(168)169)136(231)187-100(36-27-57-176-162(170)171)137(232)193-105(62-89-39-45-93(216)46-40-89)134(229)181-69-120(222)203-126(84(13)212)155(250)202-115-75-261-256-70-110-145(240)189-101(37-28-58-177-163(172)173)139(234)206-125(79(8)19-3)158(253)210-59-29-38-116(210)151(246)183-82(11)132(227)197-113(148(243)204-123)73-259-257-71-111(147(242)200-114(150(245)207-128(86(15)214)157(252)209-129(87(16)215)159(254)255)74-260-258-72-112(201-156(251)127(85(14)213)208-152(247)122(165)83(12)211)146(241)194-107(144(239)198-110)63-90-41-47-94(217)48-42-90)199-143(238)106(61-88-30-21-20-22-31-88)191-131(226)81(10)182-140(235)109(65-92-66-178-97-33-24-23-32-96(92)97)195-141(236)104(60-76(4)5)192-135(230)98(34-25-55-174-160(166)167)185-119(221)68-180-133(228)102(51-53-117(164)219)190-142(237)108(64-91-43-49-95(218)50-44-91)196-154(249)124(78(7)18-2)205-149(115)244/h20-24,30-33,39-50,66,76-87,98-116,122-129,178,211-218H,17-19,25-29,34-38,51-65,67-75,165H2,1-16H3,(H2,164,219)(H,179,225)(H,180,228)(H,181,229)(H,182,235)(H,183,246)(H,184,248)(H,185,221)(H,186,220)(H,187,231)(H,188,233)(H,189,240)(H,190,237)(H,191,226)(H,192,230)(H,193,232)(H,194,241)(H,195,236)(H,196,249)(H,197,227)(H,198,239)(H,199,238)(H,200,242)(H,201,251)(H,202,250)(H,203,222)(H,204,243)(H,205,244)(H,206,234)(H,207,245)(H,208,247)(H,209,252)(H,223,224)(H,254,255)(H4,166,167,174)(H4,168,169,175)(H4,170,171,176)(H4,172,173,177)/t77-,78-,79-,80-,81-,82-,83+,84+,85+,86+,87+,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,122-,123-,124-,125-,126-,127-,128-,129-/m0/s1
InChIKey
APXZMQUSJPSIHI-OLYMETTISA-N
Compound name
(2S,3R)-2-[[(2S,3R)-2-[[(1R,4S,7S,13S,16S,19R,22S,25S,31S,34S,37S,40S,46S,49R,52S,55S,58S,64S,67S,70S,73S,76S,79R,82R,87R,90S)-87-[[(2S,3R)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]-58-(3-amino-3-oxopropyl)-76-benzyl-7,22,52-tris[(2S)-butan-2-yl]-4,34,37,64-tetrakis(3-carbamimidamidopropyl)-31-(2-carboxyethyl)-46-[(1R)-1-hydroxyethyl]-40,55,90-tris[(4-hydroxyphenyl)methyl]-70-(1H-indol-3-ylmethyl)-16,25,73-trimethyl-67-(2-methylpropyl)-2,5,8,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80,88,91-octacosaoxo-84,85,94,95,98,99-hexathia-3,6,9,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81,89,92-octacosazatetracyclo[47.43.4.419,79.09,13]hectane-82-carbonyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

3772.6653 Da
Monoisotopic Mass

-7.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3773.6726 288.3
[M+Na]+ 3795.6545 289.1
[M-H]- 3771.6580 288.5
[M+NH4]+ 3790.6991 288.0
[M+K]+ 3811.6285 287.2
[M+H-H2O]+ 3755.6626 284.9
[M+HCOO]- 3817.6635 288.2
[M+CH3COO]- 3831.6792 288.7
[M+Na-2H]- 3793.6400 293.1
[M]+ 3772.6648 283.3
[M]- 3772.6658 283.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.